3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Carcinoma, Non-Small-Cell Lung
21
Ovarian Neoplasms
16
Lung Neoplasms
14
Endometrial Neoplasms
12
Breast Neoplasms
12
Parkinson Disease 4, Autosomal Dominant Lewy Body
10
Fallopian Tube Neoplasms
10
Squamous Cell Carcinoma of Head and Neck
7
Neoplasm Metastasis
7
Triple Negative Breast Neoplasms
5
Neoplasms
4
Esophageal Squamous Cell Carcinoma
4
Esophageal Neoplasms
4
Adenocarcinoma Of Esophagus
4
Stomach Neoplasms
3
Melanoma
3
Colorectal Neoplasms
3
Carcinoma
3
Uterine Cervical Neoplasms
2
Urinary Bladder Neoplasms
2
Peritoneal Neoplasms
2
Cholangiocarcinoma
2
Carcinoma, Transitional Cell
2
Brenner Tumor
2
Advanced Solid Tumour
2
Adenocarcinoma, Bronchiolo-Alveolar
2
Adenocarcinoma of Lung
2
Adenocarcinoma
2
Uterine Neoplasms
1
Squamous Non-small Cell Lung Cancer
1
Interventions
vinflunine
1
sacituzumab govitecan
1
Paclitaxel
1
Docetaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Locally Advanced or Metastatic Unresectable Urothelial Cancer
×
Paclitaxel
×
30 days
×
Clear all
NCT04527991
2026-06-02
TROPiCS-04
Gilead Sciences
Phase 3
Completed
711 enrolled
25 charts